Add like
Add dislike
Add to saved papers

Circulation of Dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after Dengue virus-3 (DENV-3) predominance: a single centre hospital-based study.

BACKGROUND: Delhi, a city in north India, has so far witnessed several reported outbreaks of dengue. Dengue in Delhi from being epidemic is slowly changing towards being endemic and hyper-endemic. Circulating type of the virus is also changing over the years. In the absence of an effective vaccine, dengue prevention to a major extent relies on virological surveillance, and development of effective, locally adapted control programmes. In the present study, we tried to identify the between-year non-epidemic serotype of dengue virus circulating in Delhi, during 2010-11.

METHODS: Acute-phase samples were collected from the patients attending the Institute of Liver & Biliary Sciences, New Delhi, India. Dengue diagnosis was done using WHO case definitions. All the samples were subjected to Dengue NS1 Ag ELISA and modified nested RT-PCR.

RESULTS: A total of 75 acute-phase samples were received, of which 19 (25.3%) were positive for dengue NS1 antigen. Dengue RT-PCR was positive in 14.6% (11/75) samples. All the RT-PCR isolates were of DENV-1 serotype. No case of concomitant infection with more than one serotype was observed. Median age of involvement was 23 yr (range10-86). Maximum number of cases were seen in the age group of 21-30 yr. Male to female ratio was 1.2 : 1. Maximum number of suspected dengue cases (n=79) was seen during September and October.

CONCLUSIONS: DENV-1 was circulating in Delhi in the year 2010-11 in non-epidemic period following reported predominance of DENV-3 and co-circulation of all dengue serotypes in the epidemic years 2003, 2006 and 2007.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app